ATON
ATON
NASDAQ · Biotechnology

Alphaton Capital Corp

$0.54
+0.04 (+8.79%)
As of Feb 8, 2:30 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.42M 3.23M 3.00M
Net Income -386,907 -351,594 -373,147
EPS
Profit Margin -11.3% -10.9% -12.5%
Rev Growth +21.7% +15.6% +5.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.03M 1.91M 2.41M
Total Equity 5.29M 6.20M 5.71M
D/E Ratio 0.38 0.31 0.42
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -622,705 -634,407 -526,103
Free Cash Flow -366,603 -274,517 -229,625